leukemogenicity
leukemic
leukemogenically
leukemogenic
acute lymphoblastic leukemia
acute leukemia
leukaemogenesis
leukemogenesis
leukaemic
chronic leukemia
promyeloleukemia
nonleukemic
lymphoblastic leukemia
erythroleukosis
acute lymphocytic leukemia
acute myelocytic leukemia
nonleukemia
acute myeloid leukemia
monoblastic leukaemia
histiocytic leukaemia
preleukemia
erythroleukemic
monocytic leukaemia
monoblastic leukemia
histiocytic leukemia
monocytic leukemia
leukoblastic
erythroleukemia
leukemoid
chronic myelocytic leukemia
antileukemic
ponatinib
myeloid leukemia
nonleukemogenic
leucoblastoma
antileukemia
leukocytopenia
pseudoleukaemia
hematogone
chronic lymphocytic leukemia
CD135
lenzilumab
hairy cell
monocytosis
venetoclax
idelalisib
myeloleukemia
lymphocytotoxicity
amoebocyte
aleukia
lymphocytic leukemia
chromism
talacotuzumab
lymphotoxicity
leukopenic
IGHV
lumiliximab
cytotoxically
Fanconi anemia
leukemid
smudge cell
thioguanine
cyclogenetic
lymphogenically
mogamulizumab
leukocytoclasia
chemotyping
alemtuzumab
chloraminophene
hemangiocyte
cytotoxicological
myeloblast
chromatinizable
neochromosome
bivalent
cytoablative
ubenimex
leukocytic
chromidium
tyrosine kinase inhibitor
lymphoblast
karyotin
cytogenotoxicity
chromo-
midostaurin
cytoimmunologically
cytoembryological
cytoplasmically
lymphogenously
lymphologically
leukolysis
pegaspargase
ofatumumab
cytolemmal
sialophorin